News by Subject
News by Disease
News by Date
Post Your News
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
US & Canada
Post an Event
News | News By Subject | News by Disease |
News By Date | Search News
Integrated DNA Technologies Release: Enhancing Target Enrichment With Novel Oligonucleotide Technologies
10/31/2013 9:59:23 AM
CORALVILLE, IA – 31st October 2013 – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis will be attending NGS 2013 Manchester: Applications & Bottlenecks, on November 5-6. Scientific Application Specialist at IDT, Dr Nick Downey, will present a workshop on November 5, providing delegates with an opportunity to discover how oligonucleotide probes and novel blocking oligonucleotide approaches are improving solution-based target enrichment strategies for next generation sequencing (NGS). As a chance to share expertise and form effective strategies, the workshop run by IDT is ideal for researchers wishing to improve the performance of their targeted enrichment protocols.
As an alternative to whole genome sequencing, target enrichment approaches vastly increase the efficiency of NGS, focusing in on chosen target areas of the genome linked to a specific pathway or disease state. Attendees of the workshop will discover how solution hybridization probe-based enrichment presents significant advantages over PCR-based methods, and how performance is further enhanced by oligonucleotide probes. Furthermore, a new generation of modified blocking oligonucleotides have been shown to increase on-target capture by 10-25 % and their universal barcoded domains alleviate the need for individual barcode specific blockers.
Delegates of NGS can visit the IDT booth to discover how IDT can enhance their research.
For more information please visit www.idtdna.com. Follow us on twitter @idtdna for real-time updates and insights.
Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the world, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; Leuven, Belgium; and Singapore. For more information visit www.idtdna.com.
Integrated DNA Technologies
800-328-2661 (US & Canada)
+1 319-626-8400 (outside US)
Help employers find you! Check out all the jobs and post your resume.